POINT Biopharma Global Inc., (PNT) Social Stream



POINT Biopharma Global Inc., (PNT): $8.29

0.51 (+6.56%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PNT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

POINT Biopharma Global Inc (PNT) Price Targets From Analysts

Use the tables below to see what analysts covering POINT Biopharma Global Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-16 3 $17 $8 $12.5 $7.4 68.92%
2021-12-06 4 $23 $8 $16 $7.4 116.22%
2022-02-27 5 $65 $8 $28.25 $7.4 281.76%

The Trend in the Analyst Price Target


PNT's average price target has moved up $15.75 over the prior 172 days.

Over the past 30 weeks, PNT's average upside potential has been 148.6%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-04 NA 17 8 12.50 10.66 17.26%
2021-11-16 4 17 8 12.50 9.03 38.43%
2021-12-06 4 23 8 16.00 6.22 157.23%
2021-12-06 5 23 8 16.00 6.22 157.23%
2021-12-19 5 65 8 28.25 5.60 404.46%

PNT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.2 3 0 1 1 1 5

The Trend in the Broker Recommendations


PNT's average broker recommendation rating improved by 0 over the prior 62 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, POINT Biopharma Global Inc's variance in analysts' estimates is lower than -347.22% of them.
  • To contextualize these metrics, consider that out of all US stocks, POINT Biopharma Global Inc's average analyst price target is greater than 91.34% of them.
  • POINT Biopharma Global Inc's number of analysts covering the stock is higher than 105.06% of all US stocks.
  • PNT has a higher upside potential (average analyst target price relative to current price) than 188.31% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to POINT Biopharma Global Inc are PLXP, PLRX, and PHVS.

Is PNT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5232 seconds.